Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 25 results found. Search for [ Gennova vaccine ]

Results 1 to 21 of 25
Reuters
June 1, 2021
Biological E. will run a clinical trial of Providence's vaccine in India and seek emergency use approval for it, the company said in a statement


PTI
May 21, 2021
The Centre will also take up with Moderna, Johnson and Johnson and other vaccine makers the issue of granting voluntary licence to third-party manufacturers in India on transfer of technology basis


Manoj Sharma
May 17, 2021
The current vaccine makers, Serum Institute and Bharat Biotech, alone won't be able to meet the demand. There are other players too in vaccine production, and they should be able to cater to the demand in the months ahead


Ashutosh Kumar
April 19, 2021
The government will make pre-payment to both Serum Institute of India and Bharat Biotech for the vaccine supply. \"This will serve as an incentive to the two vaccine suppliers,\" said a source


BusinessToday.In
April 19, 2021
States have been empowered to procure additional vaccine doses directly from the manufacturers, as well as open up vaccination to any category of people above the age of 18 years.


BusinessToday.In
April 19, 2021
Lockdown E-Pass for Delhi: Apply on the Delhi government's website; check out steps on how and where to apply, who requires an e-pass, and who's exempted.


BusinessToday.In
April 19, 2021
The Pune-headquartered company had received approval in December last year to start phase 1 and 2 trials for its COVID-19 vaccine candidate.


BusinessToday.In
April 19, 2021
The prime minister is likely to conduct the meeting with doctors at 4:30 pm today, while his meeting with pharmaceutical companies is scheduled at 6 pm, sources said.


PB Jayakumar, Rai Vinaykumar
April 13, 2021
Indian vaccine manufacturers, including SII, Bharat Biotech, Panacea Biotech, Sanofi's Shanta Biotech, Biological E, Hester Biosciences and Zydus Cadila, have an installed capacity to manufacture 8.2 billion doses of different vaccines per year


BusinessToday.In
January 12, 2021
Among these vaccines are those developed by Zydus Cadila, Biological E and Gennova, along with Russia's Sputnik-V vaccine


BusinessToday.In
January 4, 2021
Coronavirus vaccine in India: Adar Poonawalla, CEO of Serum Institute of India that is manufacturing Covishield had said that the company is ready to roll out its vaccine in the coming weeks


BusinessToday.In
December 20, 2020
As many as 341 new fatalities were reported in the past 24 hours, pushing the overall death toll to 1,45,477.  India's COVID-19 case fatality rate is 1.45 per cent, which is one of the lowest in the world


BusinessToday.In
December 19, 2020
The COVID-19 vaccine in India will be first offered to healthcare workers, frontline workers and persons above 50 years of age. Depending on the disease epidemiology and vaccine's availability, the remaining population will be vaccinated later on


BusinessToday.In
December 19, 2020
Despite the rise in cases, India's Covid-19 recoveries have witnessed a steep exponential rise -- from 50,000 in May to over 95 lakh in December. Recoveries are more than 30 times active cases, says  HealthMin


BusinessToday.In
December 18, 2020
COVID-19 vaccine will be introduced only when the safety is proven. As is true for other vaccines, the common side effects in some individuals could be mild fever, pain, etc. at the site of injection, said the ministry


PTI
December 16, 2020
The applications are being examined on scientific basis, using the frameworks that are scientific, frameworks that are globally aligned and ensuring that the vaccine is safe, NITI Aayog member (health) Dr V K Paul said


PB Jayakumar
December 11, 2020
As the country plans to vaccinate 30 crore people by July in the first phase, it may be difficult to bank alone on the Indian vaccines, especially Serum Institute's (SII) Covishield


BusinessToday.In
December 11, 2020
The mRNA vaccine candidate -  HGCO19 - is being developed by Pune-based company Gennova, and is supported with seed grant under the Ind-CEPI mission of Department of Biotechnology under Ministry of Science and Technology


BusinessToday.In
November 30, 2020
This is the second all-party meeting called by the government on coronavirus, which has affected over 94 lakh people across India, since the beginning of the pandemic.


PTI
November 30, 2020
Classes for freshers who enroll during the current 2020-21 academic year would however, begin from February 1, next year


PAGES 1 OF 2  12